Commentary & Opinion
Concerns Over Using ARV Therapy as Prevention Strategy
January 9, 2012
PSI's "Healthy Lives" blog reviews a recent Science magazine article written by James Shelton of USAID's Bureau of Global Health in which he raises concerns about the use of antiretroviral drugs (ARVs) as a prevention strategy. The blog notes he especially expresses concerns over drug adherence and resistance. "Dr. Shelton does not entirely dismiss the usefulness of ARVs, but seeks to look a bit more critically at how effective they are as a prevention tool," the blog states, noting that Shelton's article concludes, "ARVs are no 'magic bullet.' But ARVs' best potential is to contribute to the existing combination arsenal, which, well applied, can have a major impact in stemming the global HIV pandemic" (1/6).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)